Please login to the form below

Not currently logged in
Email:
Password:

Prosonix

This page shows the latest Prosonix news and features for those working in and with pharma, biotech and healthcare.

Circassia slumps as cat allergy vaccine fails late-stage trial

Circassia slumps as cat allergy vaccine fails late-stage trial

drugs and novel combinations gained through its acquisitions of Aerocrine and Prosonix last year.

Latest news

  • Allergy specialist Circassia buys asthma firms Allergy specialist Circassia buys asthma firms

    Circassia will pay £139m ($219m) for Aerocrine and up to £100m for Prosonix. ... fit. . “Prosonix has near-term products that help us create an allergy-asthma specialist pharmaceutical company.”.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals in May 2015 Pharma deals in May 2015

    155. Prosonix/Circassia. Corporate acquisition. Portfolio of generic respiratory products includingfluticasone. 152.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics